Novo Nordisk enters research collaboration with Flagship Pioneering
The venture capital firm brings its portfolio of life science firms to the table, while Novo Nordisk has funding at the ready for any research program that might stem from the partnership.
by marketwire, translated by daniel pedersen
Novo Nordisk and Flagship Pioneering, a life science venture capital firm based in the US, have struck a deal concerning the latter’s life science portfolio of firms, a joint press release has announced.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk terminates program on innovative insulin
For subscribers
Novo Nordisk confirms start of phase I robotic pill trial
For subscribers
